Table 2.
Treatment and clinical outcomes by ACEs.
| Intervention/clinical outcome | No ACE | ACE | Group differences | ||
|---|---|---|---|---|---|
| NSSI in last 6 months | Median | IQRa | Median | IQR | p-value |
| T0 | 60 | 30–90 | 50 | 20–120 | 0.054 |
| T1 | 40 | 15–100 | 30 | 11–72.5 | |
| T2 | 13.5 | 1.5–56 | 4 | 2–13 | |
| BDI–II scores | M | SD | M | SD | p-value |
| T0 | 32.0 | 11.2 | 34.0 | 10.6 | 0.996 |
| T1 | 27.0 | 12.8 | 24.5 | 15.4 | |
| T2 | 21.9 | 14.9 | 21.8 | 13.9 | |
| KIDSCREEN-27 | M | SD | M | SD | p-value |
| T0 | 39.4 | 6.2 | 37.3 | 6.1 | 0.489 |
| T1 | 41.7 | 6.6 | 42.1 | 7.6 | |
| T2 | 44.5 | 7.9 | 43.8 | 9.5 | |
Interquartile range.